RU96106515A - ANTI-INFECTIOUS, ANTI-INFLAMMATORY AND ANTITUMORIC MEDICINE - Google Patents
ANTI-INFECTIOUS, ANTI-INFLAMMATORY AND ANTITUMORIC MEDICINEInfo
- Publication number
- RU96106515A RU96106515A RU96106515/14A RU96106515A RU96106515A RU 96106515 A RU96106515 A RU 96106515A RU 96106515/14 A RU96106515/14 A RU 96106515/14A RU 96106515 A RU96106515 A RU 96106515A RU 96106515 A RU96106515 A RU 96106515A
- Authority
- RU
- Russia
- Prior art keywords
- alkyl
- general formula
- hydrogen atom
- inflammatory
- cation
- Prior art date
Links
- 230000002924 anti-infective Effects 0.000 title claims 2
- 230000003110 anti-inflammatory Effects 0.000 title 1
- 125000004435 hydrogen atoms Chemical group [H]* 0.000 claims 4
- 125000000217 alkyl group Chemical group 0.000 claims 3
- 125000003118 aryl group Chemical group 0.000 claims 3
- -1 hydroxy, carboxy Chemical group 0.000 claims 3
- 239000002253 acid Substances 0.000 claims 2
- 125000003342 alkenyl group Chemical group 0.000 claims 2
- 150000001450 anions Chemical class 0.000 claims 2
- 150000001768 cations Chemical class 0.000 claims 2
- 150000001875 compounds Chemical class 0.000 claims 2
- AVVWPBAENSWJCB-IVMDWMLBSA-N (3R,4R,5R)-5-[(1R)-1,2-dihydroxyethyl]oxolane-2,3,4-triol Chemical compound OC[C@@H](O)[C@H]1OC(O)[C@H](O)[C@H]1O AVVWPBAENSWJCB-IVMDWMLBSA-N 0.000 claims 1
- WQZGKKKJIJFFOK-SVZMEOIVSA-N D-galactose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-SVZMEOIVSA-N 0.000 claims 1
- 150000007513 acids Chemical class 0.000 claims 1
- 125000001931 aliphatic group Chemical group 0.000 claims 1
- 125000003545 alkoxy group Chemical group 0.000 claims 1
- 239000002260 anti-inflammatory agent Substances 0.000 claims 1
- 239000002246 antineoplastic agent Substances 0.000 claims 1
- 125000004432 carbon atoms Chemical group C* 0.000 claims 1
- 150000002148 esters Chemical class 0.000 claims 1
- 125000005843 halogen group Chemical group 0.000 claims 1
- 125000000623 heterocyclic group Chemical group 0.000 claims 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims 1
- 150000002772 monosaccharides Chemical class 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 239000011780 sodium chloride Substances 0.000 claims 1
- 0 C*(*(*1*[O+])O*)C(C)(C)C(*)(*)CC1(C)N Chemical compound C*(*(*1*[O+])O*)C(C)(C)C(*)(*)CC1(C)N 0.000 description 1
Claims (1)
или
где X и Z - атом водорода, гидрокси-, оксиалкил-, алкоксигруппы с количеством углеродных атомов от 1 до 3;
W - атом водорода, алкил-, алкенил-, алифатический, гетероциклический или ароматический циклы, ацильный радикал; R(1), R(2) - атом водорода или галогена, окси-, карбокси-, алкильные, арильные заместители; R(3), R(4) - атом водорода, алкил-, алкенил-, ароматический или гетероциклический заместитель;
n = 1 - 18, предпочтительнее 2 - 6;
2. Средство по п.1, отличающееся тем, что в качестве аниона использована N- -акридонуксусная кислота, а в качестве катиона 3-О-(N,N-диметиламино-н-пропил)-1,2; 5,6-ди-О-изопропилиден- α,D -глюкофураноза, образуя соединение общей формулы
3. Средство по п.1, отличающееся тем, что в качестве аниона применена 3-хлор 10-метиленкарбоксилат-9-акридон, в качестве катиона 1,2;3,4-О-диизопропилиден 6-О(N,N-диметиламиноэтил) α,D -галактопиранозу, образуя соединение общей формулы
R1. Anti-infective, anti-inflammatory and anti-tumor drug, which is a salt of acridonoacetic acids and monosubstituted esters of monosaccharides of the general formula:
or
where X and Z are a hydrogen atom, hydroxy, hydroxyalkyl, alkoxy groups with the number of carbon atoms from 1 to 3;
W is a hydrogen atom, alkyl, alkenyl, aliphatic, heterocyclic or aromatic rings, an acyl radical; R (1), R (2) - a hydrogen or halogen atom, hydroxy, carboxy, alkyl, aryl substituents; R (3), R (4) is a hydrogen atom, an alkyl, alkenyl, aromatic or heterocyclic substituent;
n = 1 to 18, preferably 2 to 6;
2. The tool according to claim 1, characterized in that as the anion used N-α-acridonoacetic acid, and as the cation 3-O- (N, N-dimethylamino-n-propyl) -1.2; 5,6-di-O-isopropylidene-α, D-glucofuranose, forming a compound of the general formula
3. The tool according to claim 1, characterized in that 3-chloro 10-methylenecarboxylate-9-acridone is used as an anion, 1,2; 3,4-O-diisopropylidene 6-O (N, N-dimethylaminoethyl as a cation) ) α, D -galactopyranose, forming a compound of the general formula
R
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU96106515A RU2118532C1 (en) | 1996-04-10 | 1996-04-10 | Antiinfectious, antiinflammatory and antitumor drug |
EA199800424A EA000632B1 (en) | 1996-04-10 | 1996-04-11 | Anti-infection, anti-inflammotory and anti-tumour drug |
AU65367/96A AU6536796A (en) | 1996-04-10 | 1996-04-11 | Anti-infection, anti-inflammatory and anti-tumour drug |
PCT/RU1996/000086 WO1997002034A1 (en) | 1996-04-10 | 1996-04-11 | Anti-infection, anti-inflammatory and anti-tumour drug |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU96106515A RU2118532C1 (en) | 1996-04-10 | 1996-04-10 | Antiinfectious, antiinflammatory and antitumor drug |
Publications (2)
Publication Number | Publication Date |
---|---|
RU96106515A true RU96106515A (en) | 1998-07-27 |
RU2118532C1 RU2118532C1 (en) | 1998-09-10 |
Family
ID=20178908
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU96106515A RU2118532C1 (en) | 1996-04-10 | 1996-04-10 | Antiinfectious, antiinflammatory and antitumor drug |
Country Status (4)
Country | Link |
---|---|
AU (1) | AU6536796A (en) |
EA (1) | EA000632B1 (en) |
RU (1) | RU2118532C1 (en) |
WO (1) | WO1997002034A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2197248C2 (en) * | 2001-03-20 | 2003-01-27 | Травкин Олег Викторович | Medicinal preparation eliciting immunomodulating, immunocorrecting, antiparasitic, antisclerotic, antiviral, antibacterial, antifungal, anti-inflammatory and antitumor effect and method of its preparing |
EP3713920A4 (en) * | 2017-11-20 | 2021-04-14 | Silicon Swat, Inc. | Oxoacridinyl acetic acid derivatives and methods of use |
US11414387B2 (en) | 2017-11-20 | 2022-08-16 | Stingthera, Inc. | Oxoacridinyl acetic acid derivatives and methods of use |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2337474C2 (en) * | 1973-07-24 | 1982-01-21 | Hoechst Ag, 6000 Frankfurt | Chemotherapeutically active tetrahydroacridones, processes for their preparation and compositions containing them |
DE2759468A1 (en) * | 1977-08-29 | 1979-06-07 | Sterling Drug Inc | Aminoalkoxy-acridone derivs. - useful as antiviral agents |
CZ283038B6 (en) * | 1991-01-11 | 1997-12-17 | Laboratoires Glaxo Sa | Acridine derivatives, process of their preparation and pharmaceutical preparations in which they are comprised |
RU2036198C1 (en) * | 1993-04-01 | 1995-05-27 | Товарищество с ограниченной ответственностью "Полисан" | N-METHYL- N- (α-D- GLUCOPYRANOSYL) -AMMONIUM -2-(ACRIDONE -9-ONE -10-YL) -ACETATE (CYCLOFERON) SHOWING INTERFEROGENIC, ANTIVIRAL AMONG THEM ANTI-HIV, ANTIPARASITIC, ANTIPROMOTER AND RADIOPROTECTIVE ACTIVITIES |
-
1996
- 1996-04-10 RU RU96106515A patent/RU2118532C1/en not_active IP Right Cessation
- 1996-04-11 AU AU65367/96A patent/AU6536796A/en not_active Abandoned
- 1996-04-11 WO PCT/RU1996/000086 patent/WO1997002034A1/en active Application Filing
- 1996-04-11 EA EA199800424A patent/EA000632B1/en not_active IP Right Cessation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU93005057A (en) | PHARMACEUTICAL COMPOUNDS, THYENOBENZODIAZEPINE DERIVATIVES, METHOD FOR THEIR PRODUCTION, PHARMOCOMPOSITION AND THEIR USE | |
RU92016218A (en) | DERIVATIVES OF TRIAZOLOPYRIMIDINE, THEIR APPLICATION, METHOD OF THEIR OBTAINING, FUNGICIDAL COMPOSITION, METHOD OF STRUGGLE AGAINST FUNGI | |
RU97108591A (en) | NUCLEOSIDES WITH MODIFIED SUGARS AND THEIR APPLICATION FOR THE SYNTHESIS OF OLIGONUCLEOTIDE | |
DE69127290D1 (en) | DRUG RELEASE SYSTEM FROM PORPHYRINE COMPOSITIONS AND METHOD FOR THE USE THEREOF | |
SE8400254D0 (en) | DIAGNOSTIC AGENTS | |
RU97101087A (en) | USE OF STERE COMPOUNDS FOR OBTAINING A MEDICINE, REGULATING MEIOSIS AND METHOD OF REGULATING MEIOSIS | |
RU92004429A (en) | DERIVATIVES 2- (1-PIPERASINIL) -4-PHENYL-CYCLO-ALKANOPYRIDINE | |
RU93055137A (en) | HETEROCYCLO-CYCLIC DERIVATIVES OF AMINES, METHOD OF OBTAINING, INTERMEDIATE COMPOUNDS, PHARMACEUTICAL COMPOSITION, METHOD OF TREATMENT | |
RU93054537A (en) | DERIVATIVES OF GUANIDINALKYL-1,1-BISPHOSPHONIC ACID, METHOD FOR PRODUCING AND USING THEM | |
ES2070929T3 (en) | NEW ANTIVIRAL COMPOUNDS. | |
ES535491A0 (en) | A METHOD OF PREPARING NEW BENZOIL-UREA DERIVATIVES THAT HAVE ANTI-TUMOR ACTIVITY | |
RU92016591A (en) | DERIVATIVES OF PYRIMIDINE NUCLEOSIDE | |
DK456585D0 (en) | METALLICENIUM SALTS AND THEIR USE AS CYTOSTATICS IN CANCER TREATMENT | |
RU94034117A (en) | Azole derivatives, methods of their synthesis and antifungal agent | |
ES8600243A1 (en) | Amide derivatives. | |
RU96106515A (en) | ANTI-INFECTIOUS, ANTI-INFLAMMATORY AND ANTITUMORIC MEDICINE | |
RU93005256A (en) | DERIVATIVES OF CYCLOPEPTANE AND PENTEN-β-AMINO ACIDS AND THEIR SALTS, METHOD FOR PRODUCING THEM AND ANTIBACTERIAL MEANS | |
DE3686979D1 (en) | CEPHEM CONNECTIONS AND METHOD FOR THEIR PRODUCTION. | |
HUP9903632A2 (en) | Neuraminic acid compounds, medicaments containing the same and method for producing the same medicaments | |
IT8619566A1 (en) | PERFECTED MACHINE GUN FOR DIFFERENT TYPES OF CARTRIDGES | |
RU92016314A (en) | DERIVATIVES OF DIPEPTIDES, METHOD OF THEIR RECEPTION AND PHARMACEUTICAL COMPOSITION ON THEIR BASIS | |
HUT37439A (en) | Process for production of derivatives of phosphorilized glucose-amidcarbamide-carbamate and tiocarbamate and medical preparatives consisting of such substances | |
ES8304915A1 (en) | Dioxybenzene ether derivatives, pharmaceutical compositions containing them, process for the preparation thereof and their use. | |
RU96121791A (en) | APPLICATION OF Xanthine derivatives to reduce the pathological hyperactivity of eosinophilic granulocytes, new xanthine derivatives and a method for their preparation | |
RU94002313A (en) | ESSENTIAL DERIVATIVES OF HEXAGIDRONAPHTHALINE, THEIR RECEIVING AND PHARMACEUTICAL COMPOSITION ON THEIR BASIS |